Houston Methodist. Leading Medicine.
Houston Methodist. Leading Medicine

Nantz National Alzheimer Center

Neuroimaging: A window on the

Houston Methodist Neurological Institute is pleased to present the 3rd Annual International Alzheimer Symposium, Neuroimaging: A window on the neurobiology and prevention of Alzheimer disease, will update the healthcare community on relevant topics related to the Nantz National Alzheimer Center. A distinguished group of Alzheimer disease scholars from Europe and the United States will be participating in this international symposium to discuss the latest advances in neuroimaging of Alzheimer disease and other forms of dementia in aging.


Neuroimaging provides a window into the neurobiology of Alzheimer disease. Brain structural and functional changes in the early and even pre-symptomatic stages of Alzheimer disease can be detected with magnetic resonance imaging or positron emission tomography (PET). Particularly, using amyloid markers with PET, it has been determined that abnormal amyloid deposition occurs as many as 20 years before there are any of the typical manifestations of the disease, such as memory loss. For this reason, the therapeutic approach is changing to target the pre-symptomatic stages of the disease. These highly relevant and rapid developments will be the object of this symposium, which gathers some of the leading experts on the neuroimaging of Alzheimer disease.


Gustavo C. Román, M.D.
Director, Nantz National Alzheimer Center
Jack S. Blanton Distinguished Endowed Chair
Houston Methodist Neurological Institute
Houston, Texas, USA


Jorge Barrio, Ph.D. Jorge Barrio, Ph.D.
“In vivo tau imaging in humans: Neurodegenerative diseases and brain concussions”
UCLA School of Medicine
Los Angeles, California, USA
Jorge Barrio, Ph.D. Gaëlle Chetélat, Ph.D.
“Synaptic dysfunction. Role of FDG PET: Relation with atrophy and amyloid deposition”
Institut National de la Santé et de la Recherche Médicale (INSRM)
Université de Caen, Caen, France
John Detre, M.D. John Detre, M.D.
“CBF: Role of arterial spin labeling”
University of Pennsylvania
Philadelphia, Pennsylvania, USA
Bradford Dickerson, M.D.

Bradford Dickerson, M.D.
“Volumetric measurements and BOLD imaging”
Massachusetts General Hospital
Boston, Massachusetts, USA

Kejal Kantarci, M.D. Kejal Kantarci, M.D.
“Amyloid deposition: Amyloid markers across Alzheimer disease spectrum”
Mayo Clinic College of Medicine
Rochester, Minnesota, USA
Gitte M. Knudsen, M.D., Ph.D. Gitte M. Knudsen, M.D., Ph.D.
“Neuronal loss and beyond: Unconventional markers”
Copenhagen University Hospital
Copenhagen, Denmark
Joseph Masdeu, M.D., Ph.D.

Joseph Masdeu, M.D., Ph.D.
“Neuronal loss: Unconventional markers”
“Neuroimaging in Alzheimer disease prevention”

National Institutes of Health
Bethesda, Maryland, USA

William Seeley, M.D.

William Seeley, M.D.
“Brain networks and neurodegeneration”
University of California
San Francisco, California, USA



Stanley H. Appel, M.D.
Director, Houston Methodist Neurological Institute
Peggy and Gary Edwards Distinguished Endowed Chair for ALS
Chair, Department of Neurology
Professor of Neurology, Weill Medical College of Cornell University
Houston, Texas, USA


Wednesday, October 16, 2013
8:00 - 8:30am Registration
8:00-4:30pm Symposium


Houston Methodist Research Institute
R2-306 Research Institute Auditorium
6670 Bertner Street, Houston, Texas  77030


  • Neurologists
  • Neuroradiologists
  • Geriatricians
  • Psychiatrists
  • Neuropsychologists
  • Neuroscientists
  • Family Practice
  • Internal Medicine
  • Nurses
  • Social Workers


Houston Methodist Neurological Institute
Nantz National Alzheimer Center
6560 Fannin Street, Suite 802
Houston, Texas 77030

Phone: 713-441-1150
Fax: 713-790-4990
E-mail: Alzheimer@HoustonMethodist.com